Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MiniMed, MRG (Medical Research Group) depress Medtronic's profits:

This article was originally published in Clinica

Executive Summary

Profit figures returned by Medtronic for the second quarter of fiscal 2002 were expectedly low, US analysts reported last week. Against net earnings of $309 million last year, the Minneapolis company reported a figure of $66.7 million for the current year's second quarter. This reflected the early year purchase of MiniMed and Medical Research Group (see Clinica No 960, p 1) for some $3.7 billion. These buys will continue to enhance reported revenue more than earnings per share, said Medtronic's CFO, Bob Ryan. Organic growth rates were good for the quarter, said the analysts. Sales were up 17% at $1.57 billion.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts